NeuroOne Medical Technologies Corporation
NMTC
$0.80
-$0.01-0.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -49.61% | 238.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -49.61% | 238.48% | |||
| Cost of Revenue | 16.49% | 18.67% | |||
| Gross Profit | -94.78% | 1,374.04% | |||
| SG&A Expenses | 5.83% | 10.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.32% | 98.51% | |||
| Operating Income | -24.52% | 27.32% | |||
| Income Before Tax | 11.20% | -7.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.20% | -7.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.20% | -7.88% | |||
| EBIT | -24.52% | 27.32% | |||
| EBITDA | -25.64% | 28.20% | |||
| EPS Basic | 11.46% | -4.53% | |||
| Normalized Basic EPS | -216.92% | 72.22% | |||
| EPS Diluted | 7.12% | -4.53% | |||
| Normalized Diluted EPS | -216.92% | 72.22% | |||
| Average Basic Shares Outstanding | 0.54% | 2.99% | |||
| Average Diluted Shares Outstanding | 0.54% | 2.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||